Endothelial dysfunction: The possible link between cardiovascular comorbidities and phenomenon of inflammaging from COPD
- PMID: 35984178
- PMCID: PMC9388037
- DOI: 10.1097/MD.0000000000030078
Endothelial dysfunction: The possible link between cardiovascular comorbidities and phenomenon of inflammaging from COPD
Abstract
Aging is a risk factor for many chronic noncommunicable diseases, including chronic obstructive pulmonary disease (COPD), which is often associated with cardiovascular disease (CVD). Moreover, aging is associated with a mild form of systemic inflammation. The aim of our study was to analyze the relationship between age, systemic and vascular inflammation, and the presence of CVD comorbidities in a stable COPD population. Forty COPD patients were divided into 2 age groups (<65 and ≥65 years of age), from which we collected the following inflammatory biomarkers: C-reactive protein, tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and endothelin-1 (ET-1). Elderly COPD patients had more frequent exacerbation events per year (2 vs 1, P = .06), a higher prevalence of CVD (3 vs 2, P = .04), more limited exercise tolerance (6-minute walking test distance, 343 [283-403] vs 434 [384-484]; P = .02), and mild systemic inflammation (TNF-α, 9.02 [7.08-10.96] vs 6.48 [5.21-7.76]; P = .03; ET-1, 2.24 [1.76-2.71] vs 1.67 [1.36-1.98] pg/mL; P = .04). A weak correlation between age and ET-1 (r = 0.32, P = .04) was observed. Mild systemic inflammation, characterized by a slightly increased level of TNF-α, and endothelial dysfunction, marked by elevated ET-1, could be liaisons between aging, COPD, and CVD comorbidities.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures



Similar articles
-
Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.Immunol Lett. 2018 Apr;196:1-10. doi: 10.1016/j.imlet.2018.01.004. Epub 2018 Jan 9. Immunol Lett. 2018. PMID: 29329680
-
Systemic inflammation in patients with COPD and pulmonary hypertension.Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326. Chest. 2006. PMID: 16899829
-
Sarcopenia correlates with systemic inflammation in COPD.Int J Chron Obstruct Pulmon Dis. 2017 Feb 20;12:669-675. doi: 10.2147/COPD.S130790. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28255238 Free PMC article.
-
Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention.Curr Med Res Opin. 2009 May;25(5):1235-45. doi: 10.1185/03007990902868971. Curr Med Res Opin. 2009. PMID: 19335322 Review.
-
[Chronic obstructive pulmonary disease and cardiovascular system].Tuberk Toraks. 2008;56(4):464-71. Tuberk Toraks. 2008. PMID: 19123087 Review. Turkish.
Cited by
-
Probiotics-derived butyric acid may suppress systemic inflammation in a murine model of chronic obstructive pulmonary disease (COPD).Narra J. 2025 Apr;5(1):e1332. doi: 10.52225/narra.v5i1.1332. Epub 2025 Feb 24. Narra J. 2025. PMID: 40352181 Free PMC article.
-
Unraveling the Role of Oxygen Pulse Variability in Endurance Exercise Training in Individuals with COPD: A Novel Approach to Response of Oxygen Pulse and Quality of Life in Pulmonary Rehabilitation.Int J Chron Obstruct Pulmon Dis. 2025 Jan 7;20:43-56. doi: 10.2147/COPD.S494666. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 39802037 Free PMC article.
-
Vascular endothelial dysfunction induced by 3-bromofluoranthene via MAPK-mediated-NFκB pro-inflammatory pathway and intracellular ROS generation.Arch Toxicol. 2024 Jul;98(7):2247-2259. doi: 10.1007/s00204-024-03751-0. Epub 2024 Apr 18. Arch Toxicol. 2024. PMID: 38635053 Free PMC article.
-
Clinical efficacy of transjugular intrahepatic portosystemic shunt in treating esophageal variceal bleeding in patients with liver cirrhosis.Pak J Med Sci. 2025 Apr;41(4):1138-1144. doi: 10.12669/pjms.41.4.11695. Pak J Med Sci. 2025. PMID: 40290225 Free PMC article.
-
EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.Epigenomics. 2025 Aug;17(12):793-801. doi: 10.1080/17501911.2025.2535966. Epub 2025 Jul 23. Epigenomics. 2025. PMID: 40696941 Free PMC article.
References
-
- Kennedy BK, Berger SL, Brunet A, et al. . Aging: a common driver of chronic diseases and a target for novel interventions. Cell. 2014;159:709–13. - PubMed
-
- Vogelmeier CF, Criner GJ, Martinez FJ, et al. . Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195:557–82. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials